Low levels are associated with aging, increased risk of infections (including COVID-19), cancer, neurological problems, diabetes, and more
The Food and Drug Administration (FDA) has not approved BPC-157or the vast majority of lifestyle peptidesfor human use in any capacity
Landmark 2017 Cell paper One of the foundational studies (by Baar et al.) was titled Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. This work demonstrated: In mice that were aged or given chemotherapy (accelerated ageing), treatment with FOXO4-DRI improved physical performance, fur quality, and renal function
It is naturally released during collagen damage
The skin's own collagen turnover cycle takes time, and the signalling effects of copper peptides need consistent input to translate into visible firmness, fine line improvement, and tone changes
Over time, stress, poor diet, and environmental toxins deplete glutathione levels, leading to dull skin, fatigue, and a weaker immune system